05 Nov 2019 --- Life science company Bifodan A/S has been acquired by Deerland Probiotics & Enzymes, a US-based supplier of solutions for microbiome health. The Danish company is now a wholly-owned subsidiary, with the move giving Deerland a larger global footprint. Bifodan, which is currently presenting at CPhI Worldwide – where NutritionInsight is reporting from – highlights that the acquisition offers significant growth potential, with the product portfolios of both companies set to be rolled out at a larger scale.